Summary of all studies containing PUBCHEM ID 9546800
| Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
|---|---|---|---|---|---|
| PR000349 | ST000451 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data | Animal | Mus musculus | 1-Palmitoyl-2-Arachidonoyl-Gpe (16:0/20:4) [Data] |
| PR000349 | ST000452 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data | Animal | Mus musculus | 1-Palmitoyl-2-Arachidonoyl-Gpe (16:0/20:4) [Data] |
| PR000451 | ST000617 | Validation of the application of targeted metabolomic appraoch in the diagnosis of CFS | Human | Homo sapiens | PE(36:4) [Data] |
| PR000625 | ST000899 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Human serum | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) [Data] |
| PR000627 | ST000903 | Pharmacometabolomic analysis of rat hippocampus and plasma in response to chronic stress and albiflorin treament | Animal | Rattus norvegicus | PE(36:4) [Data] |
| PR000776 | ST001157 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) | Mammal | Mus musculus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) [Data] |
| PR000776 | ST001158 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Mammal | Mus musculus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) [Data] |
| PR000840 | ST001253 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Mammal | Mus musculus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) [Data] |
| PR000967 | ST001411 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001048 | ST001639 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001121 | ST001749 | REACH Metabolomics Study | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001129 | ST001775 | Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi | Mammal | Mus musculus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001159 | ST001835 | Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001162 | ST001841 | Metabolomics of lung microdissections reveals region- and sex-specific metabolic effects of acute naphthalene exposure in mice (part II) | Mammal | Mus musculus | 2-Arachidonoyl-1-palmitoyl-sn-glycero-3-phosphoethanolamine [Data] |
| PR001180 | ST001869 | WNK463 Inhibition on Right Ventricular metabolomics | Mammal | Rattus norvegicus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001180 | ST001870 | Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats | Mammal | Rattus norvegicus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001281 | ST002017 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001282 | ST002019 | TIPs Metabolomics (blood) | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001048 | ST002088 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR000907 | ST002089 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001488 | ST002322 | Metabolomics study comparing SCAP KO and WT B cells | Cultured cells | Mus musculus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001613 | ST002498 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001715 | ST002754 | Metabolomics analysis of maternal obesity model | Mammal | Mus musculus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001737 | ST002787 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Human | Homo sapiens | PE(16:0_20:4) [Data] |
| PR001756 | ST002809 | Role of cilia in mitochondrial function | Mammal | Mus musculus;Canis lupus familiaris | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001762 | ST002818 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001762 | ST002819 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001762 | ST002820 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001764 | ST002822 | Effect of ERR Agonist in Mouse Heart Post Pressure Overload | Mammal | Mus musculus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001771 | ST002829 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001776 | ST002836 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Intestine) | Mammal | Mus musculus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001776 | ST002837 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Blood) | Mammal | Mus musculus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001809 | ST002909 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001890 | ST003038 | Untargeted lipidomics of WT and Cyp2c44(-/-) mice liver. | Mammal | Mus musculus | PE 36:4 (740.52338@8.572) [Data] |
| PR001945 | ST003131 | Untargeted Metabolomics on mouse caecal contents | Mammal | Mus musculus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001945 | ST003132 | Untargeted Metabolomics on Mouse colonic mucosa | Mammal | Mus musculus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR001883 | ST003222 | A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 | Mammal | Mus musculus | PE(16:0_20:4) [Data] |
| PR001952 | ST003277 | LC-MS/MS spatial analysis of mouse GI | Mammal | Mus musculus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR002165 | ST003520 | Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis | Human | Homo sapiens | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
| PR002182 | ST003546 | Improved Soil Health and Pasture Phytochemical Richness Underlies Improved Beef Nutrient Density in Southern US Grass-Finished Beef Systems | Mammal | Bos taurus | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* [Data] |
